Form 4: Ascendis Pharma A/S Executive Sells Shares
Insider Transaction (Form 4)
Mads Bodenhoff, SVP & PAO of Ascendis Pharma A/S, sold 3,000 shares of common stock on September 8, 2026 for $270.19 per share.
Summary
- Option exercise/conversion: acquired 3,000 Ordinary Shares at $110.00 ($330,000) on September 8, 2026; holds 3,000 after (Direct).
- Open-market sale: disposed of 3,000 Ordinary Shares at $270.19 ($810,570) on September 8, 2026 (Direct).
- Option exercise/conversion: disposed of 3,000 Warrants on September 8, 2026; holds 687 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $810,570 of stock on the open market.
Insider Transactions
Mads Bodenhoff — Officer (SVP & PAO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Ordinary Shares | 3,000 | $110 | $330.0K | 3,000 |
| 2026-09-08 | Open-market sale | Ordinary Shares | 3,000 | $270 | $810.6K | 0 |
| 2026-09-08 | Option exercise/conversion | Warrants | 3,000 | — | — | 687 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (3,000 shares) |
| 2026-09-08 | Open-market sale (3,000 shares) |
| 2026-09-08 | Option exercise/conversion (3,000 shares) |
Keywords
insider transaction, Form 4, ASND, Ascendis Pharma A/S, bearish, Mads Bodenhoff
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.